Research
Dr. Lee is an active participant in translational research and is currently involved in several research protocols as either primary or co-investigator that includes NIH, non-profit foundation, and industry support. He is active in global health, helping to spearhead HIV risk reduction efforts in both China and Africa. He has established collaborations with several other leading institutions, including The Population Council, Rockefeller University, Cornell Tech, and the Mayo Clinic. He has been listed as a New York Rising Star since 2014. He is an active peer reviewer for European Urology, Journal of Urology, British Journal of Urology International, and Advances in Urology. He has also published over 150 peer-reviewed articles and co-authored chapters in several urologic textbooks. He serves on national committees for the AUA. He serves as Section Editor for Current Bladder Dysfunction Reports and as an Editor for the Asian Journal of Urology. He is board certified by the American Board of Urology and holds a subspecialty certification in Female Pelvic Medicine and Reconstruction as well.
Current Projects:
- HIV risk reduction techniques in sub-Saharan Africa.
Bio
Dr. Richard Lee, MD MBA, completed his undergraduate degree at Duke University and his MD/MBA in Healthcare Management at the University of Pennsylvania School of Medicine and the Wharton School. He completed his surgical internship and urology residency at Weill Cornell Medical College/New York-Presbyterian Hospital. Dr. Lee completed his fellowship in Voiding Dysfunction, Female Urology, and Neurourology at both Weill Cornell Medical College/New York-Presbyterian Hospital and Memorial Sloan Kettering Cancer Center, after which he was appointed to the full-time faculty at Cornell in July 2011. He currently holds joint appointments within the Departments of Urology and Population Health Sciences. Dr. Lee currently serves as the MS Academic Director for the Executive MBA/MS in Healthcare Leadership program and the Residency Program Director for the Urology Department.
Distinctions:
Dr. Lee has been awarded numerous awards, among them, the Doctors of the World 2008 Health and Human Rights Leadership Award; Who’s Who in Medicine Higher Education, 2013; New York Rising Stars in 2014, 2015, 2016; America’s Top Surgeons, 2017; Best Doctors in America, 2019; and the American Urological Association Young Urologist of the Year Award in 2020.
Selected Publications:
- Basourakos SP, Nang QG, Ballman KV, Al Awamlh OAH, Punjani N, Ho K, Barone MA, Awori QD, Ouma D, Oketch J, Christensen AE, Hellar A, Makokha M, Isangu A, Salim R, Lija J, Gray RH, Kiboneka S, Anok A, Kigozi G, Nakabuye R, Ddamulira C, Mulooki A, Odiya S, Nazziwa R, Goldstein M, Li PS, Lee RK. ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: a multicentre, non-inferiority, adaptive, randomised controlled trial. Lancet Glob Health. 2022 Oct;10(10):e1514-e1522. doi: 10.1016/S2214-109X(22)00326-6.
- Brady SS, Bavendam TG, Bradway CK, Conroy B, Constantine ML, Dowling-Castronovo A, Epperson CN, Hijaz AK, His RS, Huss K, Kim M, Lazar J, Lee RK, Liu CK, Loizou CN, Miran S, Mody L, Norton JM, Reynolds WS, Sutcliff S, Zhang N, Hokanson JA. Noncancerous genitourinary conditions as a public health priority: how do we conceptualize the hidden burden? Urology . 2022 Aug;166:39-49. doi: 10.1016/j.urology.2021.08.040. Epub 2021 Sep 16. https://pubmed.ncbi.nlm.nih.gov/34536410.
- Al Hussein Alawamlh O, Awori QD, Barone MA, Kim SJ, Goldstein M, Li PS, Lee RK. No-flip ShangRing circumcision in 10-12 year old boys: Results from randomized clinical trials in Kenya. PLoS One. 2020 May 22;15(5):e0233150. doi: 10.1371/journal.pone.0233150. eCollection 2020.
- Awori Q, Li PS, Lee RK, Ouma D, Oundo M, Barasa M, Obura N, Mwamkita D, Simba R, Oketch J, Nyangweso N, Maina M, Kiswi N, Kirui M, Chirchir B, Goldstein M, Barone MA. Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial. PLoS One. 2019 Aug 14;14(8):e0218066. doi: 10.1371/journal.pone.0218066. eCollection 2019.
- Shoag J, Halpern J, Eisner B, Lee R, Mittal S, Barbieri CE, Shoag D. Efficacy of Prostate-Specific Antigen Screening: Use of Regression Discontinuity in the PLCO Cancer Screening Trial. JAMA Oncol. 2015 Oct;1(7):984-6. doi: 10.1001/jamaoncol.2015.2993.